MPTP-Induced Parkinsonism in Nonhuman Primates
- 1 January 1991
- book chapter
- Published by Elsevier
- Vol. 7, 168-182
- https://doi.org/10.1016/b978-0-12-185263-4.50018-2
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysisExperimental Neurology, 1990
- Methodology of microdialysis of neostriatum in hemiparkinsonian nonhuman primatesExperimental Neurology, 1990
- Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on ultrastructure of nigral neuromelanin in Macaca fascicularisNeuroscience Letters, 1989
- Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeysSynapse, 1988
- Behavioral and biochemical studies in monkeys made hemiparkinsonian by MPTPBrain Research, 1987
- “In vivo” visualization by positron emission tomography of the progressive striatal dopamine receptor damage occuring in MPTP-intoxicated non-human primatesLife Sciences, 1986
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- NEUROPEPTIDES AND DOPAMINE IN THE MARMOSETBrain, 1986
- The Clinical Syndrome of Striatal Dopamine DeficiencyNew England Journal of Medicine, 1985